KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stryker (SYK) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Stryker (SYK) over the last 17 years, with Q4 2025 value amounting to $196.0 million.

  • Stryker's Other Operating Expenses fell 8237.41% to $196.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $902.0 million, marking a year-over-year decrease of 4362.5%. This contributed to the annual value of $902.0 million for FY2025, which is 4362.5% down from last year.
  • Latest data reveals that Stryker reported Other Operating Expenses of $196.0 million as of Q4 2025, which was down 8237.41% from $262.0 million recorded in Q3 2025.
  • In the past 5 years, Stryker's Other Operating Expenses registered a high of $1.1 billion during Q4 2024, and its lowest value of $150.0 million during Q4 2021.
  • For the 5-year period, Stryker's Other Operating Expenses averaged around $239.6 million, with its median value being $167.5 million (2022).
  • As far as peak fluctuations go, Stryker's Other Operating Expenses surged by 50108.11% in 2024, and later tumbled by 8237.41% in 2025.
  • Over the past 5 years, Stryker's Other Operating Expenses (Quarter) stood at $150.0 million in 2021, then surged by 176.0% to $414.0 million in 2022, then tumbled by 55.31% to $185.0 million in 2023, then soared by 501.08% to $1.1 billion in 2024, then crashed by 82.37% to $196.0 million in 2025.
  • Its Other Operating Expenses stands at $196.0 million for Q4 2025, versus $262.0 million for Q3 2025 and $242.0 million for Q2 2025.